Children’s Hospital / The Methodist Hospital / Texas Children’s Hospital / The University of Chicago Susan R. Ross / University of Pennsylvania Hung Y. Fan / Chapel Hill John A. Zaia / University of Pennsylvania Scott E. Strome / University of California / The University of North Carolina / Harvard University / Massachusetts Institute of Technology Susan L. Welkos / National Institute of Allergy / The University of Chicago Louis V. Kirchhoff / University of Iowa Margaret Mallino / National Institute of Neurological Disorders / Hospital Gianpietro Dotti / National Cancer Institute / University of Minnesota Joseph A. Kanabrocki / Baylor College of Medicine / University Medical Center Jane Flint / University Park / University of Maryland / University of Washington School / U.S. Army Medical Research Institute / /
IndustryTerm
Treatment of Cancers / gene transfer technology / oncology protocols / final protocol / /
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES / Administration of EBV-CTLs Expressing CD30 Chimeric Receptors for Relapsed CD30+ Hodgkin / University of Maryland / Georgetown University Medical Center / U.S. Army Medical Research Institute for Infectious Diseases Nonvoting Agency Representatives Kristina C. Borror / Princeton University / Massachusetts Institute of Technology / University of California / Irvine / National Institute of Neurological Disorders and Stroke / Gene Transfer Safety Assessment Board / National Institute of Allergy and Infectious Diseases / RAC / RAC Members Seven RAC / Baylor College of Medicine / Methodist Hospital / office of Biotechnology Activities / FDA / University of Iowa / Nationwide Children’s Hospital / The Ohio State University / National Cancer Institute / Wistar Institute / National Institute of Health / Harvard University / University of Pennsylvania / Office for Human Research Protections / University of North Carolina / University of Washington School of Law / Hilton Hotel and Executive Center / Recombinant DNA Advisory Committee / Centers for Disease Control and Prevention / FDA NIH / Children’s Hospital Boston/Harvard Medical School / Federal Government / DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH RECOMBINANT DNA ADVISORY COMMITTEE Minutes / The University of Chicago / Hope office of Biotechnology Activities / U.S. Food and Drug Administration / Texas Children’s Hospital / Howard Hughes Medical Institute / University of Minnesota / /
Person
Ross / Howard Federoff / Olaf Schneewind / Gangadharan / Jeffrey S. Bartlett / Daniel M. Takefman / J. Ertl / Tom Shih / Helen Heslop / Speakers Denise Gangadhara / Jane Flint / Phillip A. Sharp / Jacqueline Corrigan-Curay / Mastroianni / Suman Mukhopadhyay / Gene Engineered / Hung Y. Fan / Bernard Roizman / David A. Williams / Craig C. Mello / Joseph A. Kanabrocki / James R. Yankaskas / Chicago Martin Schriefer / Howard J. Federoff / John A. Zaia / Barbara Savoldo / Gene Rosenthal / Scott E. Strome / Barlett / Jeffrey P. Kahn / Carlos A. Ramos / Saraswathy V. Nochur / / /
Position
management officer / D. Investigator / Lymphoma Principal Investigator / Director / Chair / medical officer / /
Product
Endomyocardial Injection / Repeat Intranodal Injections / Cyclophosphamide / Olympus E-3 Digital Camera / Administration / recall memory antibody responses / negative selection / Type-16 / germinal center / /
ProvinceOrState
California / Maryland / North Carolina / Massachusetts / /
PublishedMedium
Public Law / /
SportsEvent
NHL / /
Technology
10 protocols / stem cells / 32 A. Protocol / 38 A. Protocol / 16 A. Protocol / three protocols / Eleven protocols / Chemotherapy / final protocol / 4 A. Protocol / RECOMBINANT DNA / Biotechnology / transplantation / oncology protocols / six protocols / 11 protocols / 22 A. Protocol / Using gene transfer technology / /